Genome Structural Variation Detection via Polymer Matrix Sequencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to accurately characterize and catalog genomic variations, particularly extrachromosomal-circular DNAs, due to limitations in resolution and intercellular nonuniformity, hindering understanding of cellular dynamics and disease mechanisms.
Innovation Solution
A method involving embedding cells or extracellular vesicles in a functional polymer matrix, followed by lysis, nucleic acid fragmentation, and sequencing with modified primers, allows for high-resolution detection and analysis of structural and functional genomic variations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional sequencing methods are used to analyze genomic variations, then the process is simpler and faster, but the resolution and ability to detect heterogeneous genomic elements is insufficient
Solution Approach 1:
The method segments the genomic analysis process into distinct stages: embedding cells in polymer matrix, selective lysis to release specific nucleic acids, fragmentation, and sequencing. This segmentation allows for targeted detection of heterogeneous genomic elements while managing complexity through systematic breakdown of the analysis workflow
Solution Approach 2:
The patent introduces a polymer matrix as an intermediary substance that enables controlled lysis and selective release of nucleic acids. This intermediary facilitates the detection of heterogeneous genomic elements by providing a structured environment for cell lysis and nucleic acid extraction, thereby improving measurement precision without requiring direct manipulation of complex cellular structures
2Loss of information
If bulk sequencing is performed on cell populations, then the workflow is simpler, but intercellular nonuniformity and cell-to-cell variability are obscured
Solution Approach 1:
The method segments the sample into individual cells embedded in separate polymer matrix compartments, allowing each cell to be lysed and analyzed independently. This segmentation preserves intercellular genomic nonuniformity by preventing averaging effects that occur in bulk sequencing, while maintaining productivity through parallel processing of multiple individual cells
Solution Approach 2:
The patent applies preliminary action by embedding cells in polymer matrix before lysis, creating a structured environment that facilitates controlled release of nucleic acids from individual cells. This preliminary organization enables subsequent independent analysis of each cell's genomic content, preserving cell-to-cell variability information
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables detailed characterization of heterogeneous genomic elements, including repetitive DNAs and extrachromosomal circular DNAs, facilitating the determination of cell-type-specific genomic heterogeneity and disease mechanisms.
Implementation Method 1
fragmenting nucleic acids from the one or more cells, purified nuclei, or extracellular vesicles using a transposase
Implementation Method 2
dissolving the polymer matrix of each pearl in a chaotropic dense salt solution
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
Compositions and methods are provided for detection of dynamic loci in a genome. The methods may utilize microfluidic platforms and functionalized polymer matrices to allow determination of mechanisms of cell-type-specific, programmed genomic heterogeneity.